Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern
Department of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong
Received 22 March 1996; accepted 28 March 1996.
Correspondence: Professor J. E. Sanderson, Department of Medicine, The Chinese University of Hong Kong, 9/F Clinical Sciences Bldg. Prince of Wales Hospital, Shatin, N T, Hong Kong
Abstract
BACKGROUND: Left ventricular diastolic dysfunction is common in patients with systolic heart failure andthe restrictive type of filling pattern appears to be associated with increased cardiac mortality. Both atrial and brain (or ventricular) natriuretic peptides are also proven markers of the severity of heart failure. The aim of this study was to determine in a large cohort of patientswith systolic heart failure whether diastolic abnormalities, and in particular the restrictive filling pattern of transmitral flow velocity, correlate with plasma atrial and brain natriuretic peptide levels.
METHODS: Sixty-eight consecutive patients with symptomatic systolic heart failure (ejection fraction <0.5) underwent two-dimensional Doppler echocardiography of left ventricular systolic and diastolic function, together with measurement of atrial and brain natriuretic peptides.
RESULTS: The restrictive filling pattern was present in 62%, the abnormal relaxation pattern in 31% and only 7% were normal. Atrial and brain natriuretic peptide (ANP/BNP)levels were significantly higher in the restrictive compared to the abnormal relaxation group (ANP: 202.2±31.7 vs 102.5 ± 22.1 pg. ml–1, P=0.0l2; BNP: 277.8 ± 27.7 vs 162.4±21.9 pg. ml–1, P=0.002). In addition, a restrictive filling pattern was associated with lower ejection fractions (P=0.026), higher pulmonary artery systolic pressure (P<0.001), larger left atrial size (P=0.044), and were more likely to be in New York Heart Association class III or IV than those with an abnormal relaxation pattern (P=0.007). Both atrial and brain natriuretic peptides correlated inversely with ejection fraction (P<0.001), fractional shortening (P<0.001), and positively with pulmonary artery pressure (P=0.004 and 0.001 respectively). There were no significant correlations between single diastolic parameters and atrial or brain natriuretic peptide levels for the total patient group except between mitral peak A wave velocity and brain natriuretic peptides (r= – 0.3, P=0.01). For those with abnormal relaxation pattern mitral, valve E-wave deceleration time correlated significantly with both atrial and brain natriuretic peptide levels (P<0.01).
CONCLUSIONS: This study confirms that the restrictive filling pattern of transmitral flow velocity is a marker of more severe heart failure, as indicated by its association with higher atrial and brain natriuretic peptide levels, lower ejection fraction and higher pulmonary artery pressure. Thus, this easily obtained Doppler-derived marker of diastolic dysfunction is useful for identifying those patients with more severe heart failure.
Key Words: Heart failure • natriuretic peptides • diastole
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Celik, I. Sahin, N. Celik, S. Hascalik, L. Keskin, H. Ozcan, A. Uckan, and F. Kosar Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study Hum. Reprod., November 1, 2007; 22(11): 2992 - 2998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Yu, F. Fang, Q. Zhang, G. W.K. Yip, C. M. Li, J. Y.-S. Chan, L. Wu, and J. W.-H. Fung Improvement of Atrial Function and Atrial Reverse Remodeling After Cardiac Resynchronization Therapy for Heart Failure J. Am. Coll. Cardiol., August 21, 2007; 50(8): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, Q. Zhang, G. W.K. Yip, P.-W. Lee, L. C.C. Kum, Y.-Y. Lam, and J. W.-H. Fung Diastolic and Systolic Asynchrony in Patients With Diastolic Heart Failure: A Common But Ignored Condition J. Am. Coll. Cardiol., January 2, 2007; 49(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Scardovi, C. Coletta, N. Aspromonte, S. Perna, M. Greggi, P. D'Errigo, A. Sestili, and V. Ceci Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure Eur J Echocardiogr, January 1, 2007; 8(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Elnoamany and A. K. Abdelhameed Mitral annular motion as a surrogate for left ventricular function: Correlation with brain natriuretic peptide levels Eur J Echocardiogr, June 1, 2006; 7(3): 187 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Talens-Visconti, M. Rivera Otero, M. J. Sancho-Tello, F. G. de Burgos, L. Martinez-Dolz, B. Sevilla, V. Climent, R. Cortes, A. Salvador, F. Sogorb, et al. Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure Eur J Echocardiogr, January 1, 2006; 7(1): 45 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Sanderson BNP or echocardiography for monitoring heart failure? Eur. Heart J., October 2, 2004; 25(20): 1763 - 1764. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Patrianakos, F. I. Parthenakis, E. A. Papadimitriou, G. F. Diakakis, P. G. Tzerakis, D. Nikitovic, and P. E. Vardas Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy Eur J Heart Fail, October 1, 2004; 6(6): 735 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Magnusson, O. Melander, B. Israelsson, A. Grubb, L. Groop, and S. Jovinge Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease Diabetes Care, August 1, 2004; 27(8): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Dahlstrom Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail, March 15, 2004; 6(3): 281 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Troughton, D. L. Prior, J. J. Pereira, M. Martin, A. Fogarty, A. Morehead, T. G. Yandle, A. M. Richards, R. C. Starling, J. B. Young, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function J. Am. Coll. Cardiol., February 4, 2004; 43(3): 416 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, H. Lin, L. C. C. Kum, W.-F. Lam, W.-H. Fung, and J. E. Sanderson Evidence of atrial mechanical dysfunction by acoustic quantification in abnormal relaxation and restrictive filling patterns of diastolic dysfunction in patients with coronary artery disease Eur J Echocardiogr, December 1, 2003; 4(4): 272 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E Sanderson Diastolic heart failure: fact or fiction? Heart, November 1, 2003; 89(11): 1281 - 1282. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Maisel, J. McCord, R. M. Nowak, J. E. Hollander, A. H. B. Wu, P. Duc, T. Omland, A. B. Storrow, P. Krishnaswamy, W. T. Abraham, et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: Results from the Breathing Not Properly Multinational Study J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2010 - 2017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y.-M. Wang, J. Sanderson, M. M.-M. Sea, M. Wang, C. W.-K. Lam, P. K.-T. Li, S.-F. Lui, and J. Woo Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis Am. J. Clinical Nutrition, April 1, 2003; 77(4): 834 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. McGeoch, J. Lainchbury, G.I. Town, L. Toop, E. Espiner, and A.M. Richards Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice Eur J Heart Fail, August 1, 2002; 4(4): 479 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, K. Sakamoto, T. Yamano, M. Kikkawa, K. Zen, T. Hikosaka, T. Kubota, A. Azuma, and T. Nishimura Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1657 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lubien, A. DeMaria, P. Krishnaswamy, P. Clopton, J. Koon, R. Kazanegra, N. Gardetto, E. Wanner, and A. S. Maisel Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings Circulation, February 5, 2002; 105(5): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, E. Chau, J. E. Sanderson, K. Fan, M.-O. Tang, W.-H. Fung, H. Lin, S.-L. Kong, Y.-M. Lam, M. R.S. Hill, et al. Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure Circulation, January 29, 2002; 105(4): 438 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Persson, K. Andreasson, T. Kahan, S. V. Eriksson, B. Tidgren, P. Hjemdahl, C. Hall, and L. Erhardt Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists Eur J Heart Fail, January 1, 2002; 4(1): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cabanes, B. Richaud-Thiriez, Y. Fulla, F. Heloire, C. Vuillemard, S. Weber, and D. Dusser Brain Natriuretic Peptide Blood Levels in the Differential Diagnosis of Dyspnea Chest, December 1, 2001; 120(6): 2047 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.G Williams, G.A Cooke, D.J Wright, W.J Parsons, R.L Riley, P Marshall, and L-B Tan Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure Eur. Heart J., August 2, 2001; 22(16): 1496 - 1503. [Abstract] [PDF]
|
|
|
|
|
|
C-M Yu, B M Y Cheung, R Leung, Q Wang, W-H Lai, and C-P Lau Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction Heart, August 1, 2001; 86(2): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oxenham and N. Sharpe Prognostic stratification in heart failure: what's the point? Eur. Heart J., November 2, 2000; 21(22): 1815 - 1816. [PDF]
|
|
|
|
|
|
F M Fruhwald, A Fahrleitner, N Watzinger, H Dobnig, M Schumacher, R Maier, R Zweiker, G Leb, and W Klein N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy Heart, November 1, 1999; 82(5): 630 - 633. [Abstract] [Full Text]
|
|
|
|
|
|
A.D. Struthers Editorials: How to use natriuretic peptide levels for diagnosis and prognosis Eur. Heart J., October 1, 1999; 20(19): 1374 - 1375. [PDF]
|
|
|
|
|
|
F. M. Fruhwald, A. Fahrleitner, N. Watzinger, S. Fruhwald, H. Dobnig, M. Schumacher, R. Maier, R. Zweiker, and W. W. Klein Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy Eur. Heart J., October 1, 1999; 20(19): 1415 - 1423. [Abstract] [PDF]
|
|
|
|
|
|
K KHAN Is BNP ready for use in clinical practice? Heart, August 1, 1999; 82(2): 254 - 255. [Full Text] [PDF]
|
|
|
|
|
|
J E Sanderson, S K W Chan, C M Yu, L Y C Yeung, W M Chan, K Raymond, K W Chan, and K S Woo beta Blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol Heart, January 1, 1998; 79(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, H. Lin, H. Yang, S.-L. Kong, Q. Zhang, and S. W.-L. Lee Progression of Systolic Abnormalities in Patients With "Isolated" Diastolic Heart Failure and Diastolic Dysfunction Circulation, March 12, 2002; 105(10): 1195 - 1201. [Abstract] [Full Text] [PDF]
|
|